Five years of investigation produced a split verdict rather than an answer. The published virological record — genomic epidemiology tying earliest cases and environmental samples to the Huanan market, two-lineage introduction analyses, susceptible animals traded there — supports natural zoonotic spillover and represents the majority position in the field. The intelligence record leans differently: US agencies split for years, with the FBI (moderate confidence) and Department of Energy (low confidence) favouring a laboratory-associated origin, the CIA joining with a low-confidence lab lean in January 2025, and a German intelligence assessment reported in 2025 placing high probability on a lab incident; a US House select subcommittee endorsed the lab hypothesis in late 2024, and the official US government COVID origins page adopted it in 2025 — moves critics note are political as well as evidentiary. No agency claims high confidence; no dispositive evidence for either pathway has surfaced publicly. Both hypotheses remain scientifically viable, and asserting either as established fact misrepresents the record.

The question persists because the discriminating evidence is absent, largely by obstruction: no infected intermediate animal was ever identified (the smoking gun of SARS-1 and MERS investigations); the Wuhan Institute of Virology's databases went offline in 2019 and its records, personnel and early samples were never independently examined; raw early-case data reached international investigators late, partially, or not at all; and China dismantled the market before full sampling while promoting fringe counter-theories. WHO's own expert advisory group (SAGO) reported in 2025 that most available evidence favours zoonosis while a laboratory origin cannot be excluded — explicitly because the data needed to exclude it was withheld. Absence of the intermediate host is not proof of a leak; absence of lab transparency is not proof of one either. The honest epistemic position is weighted uncertainty — and anger at the obstruction that made it permanent.

The origins fight damaged trust independently of its answer. Early in the pandemic, the lab hypothesis was widely branded conspiracy theory — a framing shaped partly by scientists with undisclosed stakes and by organised statements (the Lancet letter organised by a party to the research in question) — before being mainstreamed as legitimate by 2021; the reversal taught a durable public lesson about premature consensus enforcement. Simultaneously, the hypothesis's political weaponisation — racialised rhetoric, evidence-free certainty, funding-agency score-settling — gave the scientific establishment genuine grounds for wariness. Both distortions damaged the middle: virologists faced harassment for zoonosis findings; origin-question scientists faced career risk from both directions. The lesson this site draws repeatedly applies at maximum strength here: uncertainty honestly labelled outperforms confident wrongness in both directions, and gatekeeping a plausible hypothesis as unspeakable is how conspiracy cultures are manufactured.

The strategic insight the shouting obscures: the two origin stories converge on overlapping policy. If zoonosis: wildlife-trade regulation, market surveillance, spillover-interface monitoring and rapid-sequencing networks. If laboratory: biosafety and biosecurity overhaul — and here the pandemic already moved policy regardless of origins: scrutiny of gain-of-function and enhanced-potential-pathogen research produced funding moratoria debates, a 2024 US policy framework tightening dual-use research oversight, and a 2025 executive order restricting dangerous gain-of-function funding; global gaps remain glaring (BSL-4 labs proliferating faster than international inspection regimes, no binding biosafety verification anywhere). Because both risks are real — history offers documented lab escapes (1977 influenza plausibly, SARS-1 repeatedly, 1979 Sverdlovsk anthrax, 2007 UK foot-and-mouth) and repeated natural spillovers — the rational portfolio funds both prevention agendas without needing the COVID verdict first. Anyone using the origins fight to defund the other side's prevention agenda has mistaken the lesson entirely.

For readers wanting the actual scorecard. Favouring zoonosis: case clustering around the market including vendors, environmental positives concentrated in the live-animal section, two viral lineages suggesting separate introductions, susceptible species documented on sale, and precedent — every prior novel coronavirus emergence was zoonotic. Favouring a research incident: the outbreak city hosting the world's leading bat-coronavirus laboratory a thousand kilometres from the nearest relative viruses, documented pre-pandemic proposals to engineer furin-cleavage-site features into SARS-like viruses (the DEFUSE proposal), reported biosafety concerns and unexplained illness among lab staff in autumn 2019, and comprehensive Chinese obstruction most consistent with something to hide — though authoritarian reflex explains obstruction without guilt. Weak arguments on both sides deserve retirement: the virus looks engineered fails genomic scrutiny; wet markets were nearby proves opportunity, not occurrence. Reasonable people weight these differently; the data to force convergence is in Wuhan, or gone.

For readers: hold the question as professionals do — a genuine unknown with evidence on both sides, majority scientific opinion favouring zoonosis, several intelligence assessments leaning laboratory at low confidence, and no prospect of resolution without Chinese transparency that shows no sign of coming. Distrust certainty in either direction; it is an identity claim, not an evidence claim. For policy attention: the productive demands are pathogen-transparency obligations in international frameworks (the post-pandemic accord negotiations), independent biosafety verification for high-containment laboratories, sustained spillover surveillance funding, and protection of scientists investigating origins questions from both political and institutional retaliation. The origins of the next pandemic are being decided now, in market regulation and laboratory oversight budgets — and unlike COVID's origin, those are questions we still get to answer.